Monte Rosa Therapeutics, Inc. - Common Stock, $0.0001 par value per share (GLUE)

CUSIP: 61225M102

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
65,015,017
Total 13F shares
39,943,480
Share change
+3,600,601
Total reported value
$559,876,587
Price per share
$14.02
Number of holders
52
Value change
+$42,034,475
Number of buys
34
Number of sells
18

Quarterly Holders Quick Answers

What is CUSIP 61225M102?
CUSIP 61225M102 identifies GLUE - Monte Rosa Therapeutics, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Monte Rosa Therapeutics, Inc. - Common Stock, $0.0001 par value per share (GLUE) as of Q1 2022

As of 31 Mar 2022, Monte Rosa Therapeutics, Inc. - Common Stock, $0.0001 par value per share (GLUE) was held by 52 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 39,943,480 shares. The largest 10 holders included NEA Management Company, LLC, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, Avoro Capital Advisors LLC, BlackRock Inc., VANGUARD GROUP INC, Cormorant Asset Management, LP, Aisling Capital Management LP, Alphabet Inc., and RTW INVESTMENTS, LP. This page lists 52 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.